Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Heron Therapeutics (HRTX)

Heron Therapeutics (HRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,940,599
  • Shares Outstanding, K 90,051
  • Annual Sales, $ 77,470 K
  • Annual Income, $ -178,840 K
  • 60-Month Beta 1.54
  • Price/Sales 12.19
  • Price/Cash Flow N/A
  • Price/Book 7.23

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.60
  • Number of Estimates 6
  • High Estimate -0.47
  • Low Estimate -0.72
  • Prior Year -0.63
  • Growth Rate Est. (year over year) +4.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.67 +4.26%
on 01/10/20
25.75 -16.31%
on 12/24/19
-3.75 (-14.82%)
since 12/17/19
3-Month
18.28 +17.86%
on 10/18/19
26.81 -19.62%
on 12/04/19
+2.95 (+15.86%)
since 10/17/19
52-Week
15.68 +37.44%
on 08/07/19
28.70 -24.91%
on 02/22/19
-5.24 (-19.56%)
since 01/17/19

Most Recent Stories

More News
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important...

JPM : 138.20 (+0.69%)
HRTX : 21.55 (-5.94%)
Look for Shares of Heron Therapeuti to Potentially Rebound after Yesterday's 1.24% Sell Off

Heron Therapeuti (NASDAQ:HRTX) traded in a range yesterday that spanned from a low of $20.86 to a high of $21.35. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of...

HRTX : 21.55 (-5.94%)
Heron Therapeuti Set to Possibly Rebound After Yesterday's Selloff of 2.03%

Heron Therapeuti (NASDAQ:HRTX) traded in a range yesterday that spanned from a low of $24.13 to a high of $24.82. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of...

HRTX : 21.55 (-5.94%)
Heron Therapeuti Shares Up 20.9% Since SmarTrend's Buy Recommendation (HRTX)

SmarTrend identified an Uptrend for Heron Therapeuti (NASDAQ:HRTX) on October 28th, 2019 at $20.46. In approximately 2 months, Heron Therapeuti has returned 20.87% as of today's recent price of $24.73....

HRTX : 21.55 (-5.94%)
After Yesterday's Decline of 2.61%, Heron Therapeuti Offers Investors Better Value

Heron Therapeuti (NASDAQ:HRTX) traded in a range yesterday that spanned from a low of $24.61 to a high of $25.62. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of...

HRTX : 21.55 (-5.94%)
Drug Delivery Across Blood Brain Barrier Market Worth $4.6 Billion by 2026

The success rate for cancer therapies has been limited due to a combination of factors, such as the treatment/drug's lack of penetration through the blood brain barrier. Reports say that the global drug...

CNSP : 4.33 (-2.91%)
AMRX : 5.10 (-4.67%)
MIRM : 20.23 (-6.26%)
AXSM : 90.34 (-2.31%)
HRTX : 21.55 (-5.94%)
Heron Therapeutics Announces Publication of the Mechanism of Action Data for HTX-011, a Dual-Acting Local Anesthetic Being Developed for Management of Postoperative Pain

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important...

HRTX : 21.55 (-5.94%)
Uptrend Call Working As Heron Therapeuti Stock Rises 26.3% (HRTX)

SmarTrend identified an Uptrend for Heron Therapeuti (NASDAQ:HRTX) on October 28th, 2019 at $20.46. In approximately 2 month, Heron Therapeuti has returned 26.34% as of today's recent price of $25.85....

HRTX : 21.55 (-5.94%)
Moving Average Crossover Alert: Heron Therapeutics

Heron Therapeutics is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

HRTX : 21.55 (-5.94%)
Heron Therapeuti Rises 1.64% on Heavy Volume: Watch For Potential Pullback

Heron Therapeuti (NASDAQ:HRTX) traded in a range yesterday that spanned from a low of $26.38 to a high of $26.81. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high...

HRTX : 21.55 (-5.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade HRTX with:

Business Summary

Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting....

See More

Key Turning Points

2nd Resistance Point 23.74
1st Resistance Point 22.65
Last Price 21.55
1st Support Level 20.98
2nd Support Level 20.41

See More

52-Week High 28.70
Fibonacci 61.8% 23.73
Fibonacci 50% 22.19
Last Price 21.55
Fibonacci 38.2% 20.65
52-Week Low 15.68

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar